广济药业(000952.SZ)：拟对生物研究院减少注册资本2200万元

Core Viewpoint - Guangji Pharmaceutical (000952.SZ) announced a capital reduction for its wholly-owned subsidiary, the Biological Research Institute, from RMB 50 million to RMB 28 million, reflecting strategic planning and operational needs [1] Group 1: Capital Reduction Details - The registered capital of the Biological Research Institute will be reduced by RMB 22 million, resulting in a new registered capital of RMB 28 million [1] - As of the announcement date, the company has contributed RMB 24.5996 million in cash to the Biological Research Institute [1] - The company will maintain 100% ownership of the Biological Research Institute, ensuring no changes to the consolidated financial statements [1] Group 2: Authorization and Procedures - The company's board of directors has authorized relevant personnel to handle all matters related to the capital reduction, including determining the reduction plan and processing business registration changes [1]